Genalyte Lands $11,800,000 Series B Financing

  • Feed Type
  • Date
    3/31/2012
  • Company Name
    Genalyte
  • Mailing Address
    3030 Bunker Hill St San Diego, CA 92109
  • Company Description
    Over the past three years the team’s mission has been to develop instrument systems, hardware, software and consumables, making multiplex protein and nucleic acid testing from a single sample the standard in the Research, Life Science and Clinical Diagnostic market.
  • Website
    http://www.genalyte.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,800,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Genalyte intends to use the new funds primarily for commercialization of its Maverick(TM) platform and its highly multiplexed panels for autoimmune and immunoassay applications.
  • M&A Terms
  • Venture Investor
    Claremont Creek Ventures
  • Venture Investor
    Undisclosed